Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX‐FAST) Study

In this randomized, double‐blind, multicenter study, patients whose blood pressure (BP) was uncontrolled by monotherapy were switched directly to amlodipine/valsartan 5/160 mg (n=443) or 10/160 mg (n=451). After 16 weeks, BP control (levels

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2008-03, Vol.10 (3), p.185-194
Hauptverfasser:	Allemann, Yves, Fraile, Belen, Lambert, Michel, Barbier, Michaela, Ferber, Philippe, Izzo, Joseph L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amlodipine - adverse effects Amlodipine - therapeutic use Angiotensin II Type 1 Receptor Blockers - adverse effects Angiotensin II Type 1 Receptor Blockers - therapeutic use Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Blood Pressure - drug effects Calcium Channel Blockers - adverse effects Calcium Channel Blockers - therapeutic use Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Dose-Response Relationship, Drug Double-Blind Method Drug Therapy, Combination Humans Hydrochlorothiazide - adverse effects Hydrochlorothiazide - therapeutic use Hypertension - drug therapy Original Papers Retreatment Tetrazoles - adverse effects Tetrazoles - therapeutic use Valine - adverse effects Valine - analogs & derivatives Valine - therapeutic use Valsartan
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this randomized, double‐blind, multicenter study, patients whose blood pressure (BP) was uncontrolled by monotherapy were switched directly to amlodipine/valsartan 5/160 mg (n=443) or 10/160 mg (n=451). After 16 weeks, BP control (levels
ISSN:	1524-6175 1751-7176
DOI:	10.1111/j.1751-7176.2008.07516.x